426 related articles for article (PubMed ID: 32171687)
1. Oncogene-induced senescence: From biology to therapy.
Zhu H; Blake S; Kusuma FK; Pearson RB; Kang J; Chan KT
Mech Ageing Dev; 2020 Apr; 187():111229. PubMed ID: 32171687
[TBL] [Abstract][Full Text] [Related]
2. Regulation of senescence and the SASP by the transcription factor C/EBPβ.
Salotti J; Johnson PF
Exp Gerontol; 2019 Dec; 128():110752. PubMed ID: 31648009
[TBL] [Abstract][Full Text] [Related]
3. Oncogene-induced senescence: a double edged sword in cancer.
Liu XL; Ding J; Meng LH
Acta Pharmacol Sin; 2018 Oct; 39(10):1553-1558. PubMed ID: 29620049
[TBL] [Abstract][Full Text] [Related]
4. Notch and Senescence.
Hoare M; Narita M
Adv Exp Med Biol; 2018; 1066():299-318. PubMed ID: 30030833
[TBL] [Abstract][Full Text] [Related]
5. The Immortal Senescence.
Bianchi-Smiraglia A; Lipchick BC; Nikiforov MA
Methods Mol Biol; 2017; 1534():1-15. PubMed ID: 27812863
[TBL] [Abstract][Full Text] [Related]
6. The role of the NORE1A tumor suppressor in Oncogene-Induced Senescence.
Barnoud T; Schmidt ML; Donninger H; Clark GJ
Cancer Lett; 2017 Aug; 400():30-36. PubMed ID: 28455242
[TBL] [Abstract][Full Text] [Related]
7. Reshaping of the tumor microenvironment by cellular senescence: An opportunity for senotherapies.
D'Ambrosio M; Gil J
Dev Cell; 2023 Jun; 58(12):1007-1021. PubMed ID: 37339603
[TBL] [Abstract][Full Text] [Related]
8. Keeping the senescence secretome under control: Molecular reins on the senescence-associated secretory phenotype.
Malaquin N; Martinez A; Rodier F
Exp Gerontol; 2016 Sep; 82():39-49. PubMed ID: 27235851
[TBL] [Abstract][Full Text] [Related]
9. Genes and pathways involved in senescence bypass identified by functional genetic screens.
Roupakia E; Markopoulos GS; Kolettas E
Mech Ageing Dev; 2021 Mar; 194():111432. PubMed ID: 33422562
[TBL] [Abstract][Full Text] [Related]
10. Non-Cell-Autonomous Regulation of Cellular Senescence in Cancer.
Di Mitri D; Alimonti A
Trends Cell Biol; 2016 Mar; 26(3):215-226. PubMed ID: 26564316
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs linking inflamm-aging, cellular senescence and cancer.
Olivieri F; Rippo MR; Monsurrò V; Salvioli S; Capri M; Procopio AD; Franceschi C
Ageing Res Rev; 2013 Sep; 12(4):1056-68. PubMed ID: 23688930
[TBL] [Abstract][Full Text] [Related]
12. Tumor dormancy, oncogene addiction, cellular senescence, and self-renewal programs.
Bellovin DI; Das B; Felsher DW
Adv Exp Med Biol; 2013; 734():91-107. PubMed ID: 23143977
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic strategies targeting cellular senescence for cancer and other diseases.
Wang X; Fukumoto T; Noma KI
J Biochem; 2024 Apr; 175(5):525-537. PubMed ID: 38366629
[TBL] [Abstract][Full Text] [Related]
14. PTBP1-Mediated Alternative Splicing Regulates the Inflammatory Secretome and the Pro-tumorigenic Effects of Senescent Cells.
Georgilis A; Klotz S; Hanley CJ; Herranz N; Weirich B; Morancho B; Leote AC; D'Artista L; Gallage S; Seehawer M; Carroll T; Dharmalingam G; Wee KB; Mellone M; Pombo J; Heide D; Guccione E; Arribas J; Barbosa-Morais NL; Heikenwalder M; Thomas GJ; Zender L; Gil J
Cancer Cell; 2018 Jul; 34(1):85-102.e9. PubMed ID: 29990503
[TBL] [Abstract][Full Text] [Related]
15. A recurrent chromosomal inversion suffices for driving escape from oncogene-induced senescence via subTAD reorganization.
Zampetidis CP; Galanos P; Angelopoulou A; Zhu Y; Polyzou A; Karamitros T; Kotsinas A; Lagopati N; Mourkioti I; Mirzazadeh R; Polyzos A; Garnerone S; Mizi A; Gusmao EG; Sofiadis K; Gál Z; Larsen DH; Pefani DE; Demaria M; Tsirigos A; Crosetto N; Maya-Mendoza A; Papaspyropoulos A; Evangelou K; Bartek J; Papantonis A; Gorgoulis VG
Mol Cell; 2021 Dec; 81(23):4907-4923.e8. PubMed ID: 34793711
[TBL] [Abstract][Full Text] [Related]
16. Assessing Functional Roles of the Senescence-Associated Secretory Phenotype (SASP).
Malaquin N; Tu V; Rodier F
Methods Mol Biol; 2019; 1896():45-55. PubMed ID: 30474839
[TBL] [Abstract][Full Text] [Related]
17. Caveolin-1, a master regulator of cellular senescence.
Volonte D; Galbiati F
Cancer Metastasis Rev; 2020 Jun; 39(2):397-414. PubMed ID: 32279119
[TBL] [Abstract][Full Text] [Related]
18. Oncogene-induced senescence and its role in tumor suppression.
Reddy JP; Li Y
J Mammary Gland Biol Neoplasia; 2011 Sep; 16(3):247-56. PubMed ID: 21681694
[TBL] [Abstract][Full Text] [Related]
19. The Senescence-associated Secretory Phenotype Mediates Oncogene-induced Senescence in Pediatric Pilocytic Astrocytoma.
Buhl JL; Selt F; Hielscher T; Guiho R; Ecker J; Sahm F; Ridinger J; Riehl D; Usta D; Ismer B; Sommerkamp AC; Martinez-Barbera JP; Wefers AK; Remke M; Picard D; Pusch S; Gronych J; Oehme I; van Tilburg CM; Kool M; Kuhn D; Capper D; von Deimling A; Schuhmann MU; Herold-Mende C; Korshunov A; Brummer T; Pfister SM; Jones DTW; Witt O; Milde T
Clin Cancer Res; 2019 Mar; 25(6):1851-1866. PubMed ID: 30530705
[TBL] [Abstract][Full Text] [Related]
20. Impact of senescence-associated secretory phenotype and its potential as a therapeutic target for senescence-associated diseases.
Watanabe S; Kawamoto S; Ohtani N; Hara E
Cancer Sci; 2017 Apr; 108(4):563-569. PubMed ID: 28165648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
